Diffuse infantile fibromatosis (English Wikipedia)

Analysis of information sources in references of the Wikipedia article "Diffuse infantile fibromatosis" in English language version.

refsWebsite

Global rank English rank

19nih.gov

4^th place

11doi.org

2^nd place

4semanticscholar.org

11^th place

8^th place

2cancer.gov

1,684^th place

1,350^th place

1rarediseases.org

5,181^st place

3,260^th place

1clevelandclinic.org

4,925^th place

3,597^th place

1umassmed.edu

low place

1ncl.ac.uk

4,362^nd place

3,162^nd place

1news-medical.net

8,069^th place

7,681^st place

cancer.gov

"Desmoid Tumor - NCI". www.cancer.gov. 2019-02-27. Retrieved 2022-08-01.
"Infantile Myofibromatosis - NCI". www.cancer.gov. 2020-07-22. Retrieved 2022-07-28.

clevelandclinic.org

my.clevelandclinic.org

"Somatic Mutation vs. Germline Mutation". Cleveland Clinic. Retrieved 2022-07-29.

doi.org

Kameda N, Atobe T, Akima M, Fukuoka Y, Ikeno Y, Saito M (November 1978). "Diffuse infantile fibromatosis". Acta Pathologica Japonica. 28 (6): 957–962. doi:10.1111/j.1440-1827.1978.tb01284.x. PMID 735826. S2CID 33395556.
Allen PW (September 1977). "The fibromatoses: a clinicopathologic classification based on 140 cases". The American Journal of Surgical Pathology. 1 (3): 255–270. doi:10.1097/00000478-197709000-00007. PMID 920873. S2CID 41764536.
Larralde M, Ferrari B, Martinez JP, Barbieri MA, Méndez JH, Casas J (December 2017). "Infantile myofibromatosis". Anais Brasileiros de Dermatologia. 92 (6): 854–857. doi:10.1590/abd1806-4841.20175001. PMC 5786406. PMID 29364448.
Guérit E, Arts F, Dachy G, Boulouadnine B, Demoulin JB (April 2021). "PDGF receptor mutations in human diseases". Cellular and Molecular Life Sciences. 78 (8): 3867–3881. doi:10.1007/s00018-020-03753-y. PMC 11072557. PMID 33449152. S2CID 231612187.
Wu D, Wang S, Oliveira DV, Del Gaudio F, Vanlandewijck M, Lebouvier T, et al. (January 2021). "The infantile myofibromatosis NOTCH3 L1519P mutation leads to hyperactivated ligand-independent Notch signaling and increased PDGFRB expression". Disease Models & Mechanisms. 14 (2): dmm046300. doi:10.1242/dmm.046300. PMC 7927659. PMID 33509954.
Hettmer S, Dachy G, Seitz G, Agaimy A, Duncan C, Jongmans M, et al. (October 2021). "Genetic testing and surveillance in infantile myofibromatosis: a report from the SIOPE Host Genome Working Group". Familial Cancer. 20 (4): 327–336. doi:10.1007/s10689-020-00204-2. PMC 8484085. PMID 32888134.
Carruthers V, Barnett S, Rees R, Arif T, Slater O, Ramanujachar R, et al. (July 2022). "Clinical utility of vinblastine therapeutic drug monitoring for the treatment of infantile myofibroma patients: A case series". Pediatric Blood & Cancer. 69 (7): e29722. doi:10.1002/pbc.29722. PMID 35441483. S2CID 248263569.
Mashiah J, Hadj-Rabia S, Dompmartin A, Harroche A, Laloum-Grynberg E, Wolter M, et al. (August 2014). "Infantile myofibromatosis: a series of 28 cases". Journal of the American Academy of Dermatology. 71 (2): 264–270. doi:10.1016/j.jaad.2014.03.035. PMID 24894456.
Mynatt CJ, Feldman KA, Thompson LD (September 2011). "Orbital infantile myofibroma: a case report and clinicopathologic review of 24 cases from the literature". Head and Neck Pathology. 5 (3): 205–215. doi:10.1007/s12105-011-0260-4. PMC 3173528. PMID 21512784.
Römer T, Wagner N, Braunschweig T, Meyer R, Elbracht M, Kontny U, Moser O (June 2021). "Aggressive infantile myofibromatosis with intestinal involvement". Molecular and Cellular Pediatrics. 8 (1): 7. doi:10.1186/s40348-021-00117-9. PMC 8208328. PMID 34132909.
Parikh A, Driscoll CA, Crowley H, York T, Dachy G, Demoulin JB, Hoffman SB (November 2020). "Diagnostic limitations and considerations in the imaging evaluation of advanced multicentric infantile myofibromatosis". Radiology Case Reports. 15 (11): 2440–2444. doi:10.1016/j.radcr.2020.09.029. PMC 7522587. PMID 33014229.

ncl.ac.uk

eprints.ncl.ac.uk

Carruthers V, Barnett S, Rees R, Arif T, Slater O, Ramanujachar R, et al. (July 2022). "Clinical utility of vinblastine therapeutic drug monitoring for the treatment of infantile myofibroma patients: A case series". Pediatric Blood & Cancer. 69 (7): e29722. doi:10.1002/pbc.29722. PMID 35441483. S2CID 248263569.

news-medical.net

"What is Infantile Myofibromatosis?". News-Medical.net. 2022-07-07. Retrieved 2022-08-01.

nih.gov

pubmed.ncbi.nlm.nih.gov

Kameda N, Atobe T, Akima M, Fukuoka Y, Ikeno Y, Saito M (November 1978). "Diffuse infantile fibromatosis". Acta Pathologica Japonica. 28 (6): 957–962. doi:10.1111/j.1440-1827.1978.tb01284.x. PMID 735826. S2CID 33395556.
Allen PW (September 1977). "The fibromatoses: a clinicopathologic classification based on 140 cases". The American Journal of Surgical Pathology. 1 (3): 255–270. doi:10.1097/00000478-197709000-00007. PMID 920873. S2CID 41764536.
Larralde M, Ferrari B, Martinez JP, Barbieri MA, Méndez JH, Casas J (December 2017). "Infantile myofibromatosis". Anais Brasileiros de Dermatologia. 92 (6): 854–857. doi:10.1590/abd1806-4841.20175001. PMC 5786406. PMID 29364448.
Guérit E, Arts F, Dachy G, Boulouadnine B, Demoulin JB (April 2021). "PDGF receptor mutations in human diseases". Cellular and Molecular Life Sciences. 78 (8): 3867–3881. doi:10.1007/s00018-020-03753-y. PMC 11072557. PMID 33449152. S2CID 231612187.
Wu D, Wang S, Oliveira DV, Del Gaudio F, Vanlandewijck M, Lebouvier T, et al. (January 2021). "The infantile myofibromatosis NOTCH3 L1519P mutation leads to hyperactivated ligand-independent Notch signaling and increased PDGFRB expression". Disease Models & Mechanisms. 14 (2): dmm046300. doi:10.1242/dmm.046300. PMC 7927659. PMID 33509954.
Hettmer S, Dachy G, Seitz G, Agaimy A, Duncan C, Jongmans M, et al. (October 2021). "Genetic testing and surveillance in infantile myofibromatosis: a report from the SIOPE Host Genome Working Group". Familial Cancer. 20 (4): 327–336. doi:10.1007/s10689-020-00204-2. PMC 8484085. PMID 32888134.
Carruthers V, Barnett S, Rees R, Arif T, Slater O, Ramanujachar R, et al. (July 2022). "Clinical utility of vinblastine therapeutic drug monitoring for the treatment of infantile myofibroma patients: A case series". Pediatric Blood & Cancer. 69 (7): e29722. doi:10.1002/pbc.29722. PMID 35441483. S2CID 248263569.
Mashiah J, Hadj-Rabia S, Dompmartin A, Harroche A, Laloum-Grynberg E, Wolter M, et al. (August 2014). "Infantile myofibromatosis: a series of 28 cases". Journal of the American Academy of Dermatology. 71 (2): 264–270. doi:10.1016/j.jaad.2014.03.035. PMID 24894456.
Mynatt CJ, Feldman KA, Thompson LD (September 2011). "Orbital infantile myofibroma: a case report and clinicopathologic review of 24 cases from the literature". Head and Neck Pathology. 5 (3): 205–215. doi:10.1007/s12105-011-0260-4. PMC 3173528. PMID 21512784.
Römer T, Wagner N, Braunschweig T, Meyer R, Elbracht M, Kontny U, Moser O (June 2021). "Aggressive infantile myofibromatosis with intestinal involvement". Molecular and Cellular Pediatrics. 8 (1): 7. doi:10.1186/s40348-021-00117-9. PMC 8208328. PMID 34132909.
Parikh A, Driscoll CA, Crowley H, York T, Dachy G, Demoulin JB, Hoffman SB (November 2020). "Diagnostic limitations and considerations in the imaging evaluation of advanced multicentric infantile myofibromatosis". Radiology Case Reports. 15 (11): 2440–2444. doi:10.1016/j.radcr.2020.09.029. PMC 7522587. PMID 33014229.

ncbi.nlm.nih.gov

Larralde M, Ferrari B, Martinez JP, Barbieri MA, Méndez JH, Casas J (December 2017). "Infantile myofibromatosis". Anais Brasileiros de Dermatologia. 92 (6): 854–857. doi:10.1590/abd1806-4841.20175001. PMC 5786406. PMID 29364448.
Guérit E, Arts F, Dachy G, Boulouadnine B, Demoulin JB (April 2021). "PDGF receptor mutations in human diseases". Cellular and Molecular Life Sciences. 78 (8): 3867–3881. doi:10.1007/s00018-020-03753-y. PMC 11072557. PMID 33449152. S2CID 231612187.
Wu D, Wang S, Oliveira DV, Del Gaudio F, Vanlandewijck M, Lebouvier T, et al. (January 2021). "The infantile myofibromatosis NOTCH3 L1519P mutation leads to hyperactivated ligand-independent Notch signaling and increased PDGFRB expression". Disease Models & Mechanisms. 14 (2): dmm046300. doi:10.1242/dmm.046300. PMC 7927659. PMID 33509954.
Hettmer S, Dachy G, Seitz G, Agaimy A, Duncan C, Jongmans M, et al. (October 2021). "Genetic testing and surveillance in infantile myofibromatosis: a report from the SIOPE Host Genome Working Group". Familial Cancer. 20 (4): 327–336. doi:10.1007/s10689-020-00204-2. PMC 8484085. PMID 32888134.
Mynatt CJ, Feldman KA, Thompson LD (September 2011). "Orbital infantile myofibroma: a case report and clinicopathologic review of 24 cases from the literature". Head and Neck Pathology. 5 (3): 205–215. doi:10.1007/s12105-011-0260-4. PMC 3173528. PMID 21512784.
Römer T, Wagner N, Braunschweig T, Meyer R, Elbracht M, Kontny U, Moser O (June 2021). "Aggressive infantile myofibromatosis with intestinal involvement". Molecular and Cellular Pediatrics. 8 (1): 7. doi:10.1186/s40348-021-00117-9. PMC 8208328. PMID 34132909.
Parikh A, Driscoll CA, Crowley H, York T, Dachy G, Demoulin JB, Hoffman SB (November 2020). "Diagnostic limitations and considerations in the imaging evaluation of advanced multicentric infantile myofibromatosis". Radiology Case Reports. 15 (11): 2440–2444. doi:10.1016/j.radcr.2020.09.029. PMC 7522587. PMID 33014229.

rarediseases.info.nih.gov

"Infantile myofibromatosis - About the Disease - Genetic and Rare Diseases Information Center". rarediseases.info.nih.gov. Retrieved 2022-07-28.

rarediseases.org

"Infantile Myofibromatosis". NORD (National Organization for Rare Disorders). 2020. Retrieved 2022-07-28.

semanticscholar.org

api.semanticscholar.org

Kameda N, Atobe T, Akima M, Fukuoka Y, Ikeno Y, Saito M (November 1978). "Diffuse infantile fibromatosis". Acta Pathologica Japonica. 28 (6): 957–962. doi:10.1111/j.1440-1827.1978.tb01284.x. PMID 735826. S2CID 33395556.
Allen PW (September 1977). "The fibromatoses: a clinicopathologic classification based on 140 cases". The American Journal of Surgical Pathology. 1 (3): 255–270. doi:10.1097/00000478-197709000-00007. PMID 920873. S2CID 41764536.
Guérit E, Arts F, Dachy G, Boulouadnine B, Demoulin JB (April 2021). "PDGF receptor mutations in human diseases". Cellular and Molecular Life Sciences. 78 (8): 3867–3881. doi:10.1007/s00018-020-03753-y. PMC 11072557. PMID 33449152. S2CID 231612187.
Carruthers V, Barnett S, Rees R, Arif T, Slater O, Ramanujachar R, et al. (July 2022). "Clinical utility of vinblastine therapeutic drug monitoring for the treatment of infantile myofibroma patients: A case series". Pediatric Blood & Cancer. 69 (7): e29722. doi:10.1002/pbc.29722. PMID 35441483. S2CID 248263569.

umassmed.edu

"How do tumors grow and spread?". UMass Chan Medical School. MCCB. 28 August 2015. Retrieved 2022-07-26.